A little love warm true feelings
Release time:
2020-08-14
little love warm true feelings
unexpected circumstances, people have misfortune. Mao Zhishun and Du Bo'an, old employees of the city pharmaceutical company, were successively found to have gastric cardia cancer and nasopharyngeal carcinoma. The sudden bad news made the two sick old employees and their families bear great economic and mental pressure. It also made all the employees of the company feel extremely worried. Yuan Jie, secretary of the general party branch of the company, and others visited their homes as soon as possible on behalf of the company.
In order to help them solve their practical difficulties, the general party branch of the company held an enlarged meeting on the afternoon of November 12 9 . It was unanimously agreed that it was the bounden duty of all party members to lend a helping hand to needy employees. It studied and deployed charity donation activities, issued a charity donation initiative to all party members of the company, and required all party branches to mobilize charity donations within the scope after the party members, at the same time, it also promotes to ordinary employees, please help the two old employees as much as you can, help them overcome the disease and recover as soon as possible.
As the song goes: As long as everyone gives a little love, the world will become a better world. Shortly after the enlarged meeting of the general party branch, "well-informed" employees came to fan tufa, a member of the general party branch, to donate money. when the general party branch of the company issued a love donation initiative in the wechat group of party members, members of the management team such as yuan Jie and Wu weisheng took the lead in donating money. red envelopes of love from party members and cadres were sent one after another. non-party members also donated enthusiastically in the form of cash. some employees had no cash, also through WeChat donations, everyone has extended a helping hand, generously donated their money, and gave their own love. You are one hundred and two hundred. The love and blessings of the company's employees have gathered together. In less than two days of donation activities, a total of donations 13740 yuan was raised. On the afternoon of
12 , Yuan Jie and his party 4 , on behalf of all the employees of the company, came to visit Mao Zhishun and Du Boan's homes and sent their love donations to them. When Mao Zhishun took the red envelope of love, he and his wife both shed tears of emotion and choked up. Du Bo'an also repeatedly said "thank you, thank you all". They all thanked the company for its warm family, the organization for its care, and the kindness of colleagues like brothers and sisters. They also said that they would strengthen their confidence, actively cooperate with the treatment and return to work as soon as possible.
The disease is ruthless and there is love in the world. A little love, warm true feelings. We firmly believe that donation is not the most important thing. The most important thing is to let the two sick employees know that the company's party, government, labor organization and all employees of the company are concerned about them. Although the charity of colleagues can only slightly relieve the economic pressure of Mao Zhishun and Du Bo'an, it can also express the care of the organization and colleagues and increase their confidence in overcoming the disease.
This donation activity reflects the spirit of unity and mutual assistance of all employees of the municipal pharmaceutical company, and once again demonstrates the city pharmaceutical company's enthusiasm for participating in social welfare undertakings, caring for employees' work and life, and being a socially responsible enterprise.
In the city pharmaceutical company, we experience the touch and strength together, and convey the warmth of the world together. (Fan Tufa)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page